Patent Assignment
Reel/Frame 053649/0515
Assignment of Assignor's Interest
Recorded: 2020-08-31
Pages: 13
Assignor
HOWARD, PHILIP WILSON
Executed: 2016-01-13
Assignee
MEDIMMUNE LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CB21 6GH, UNITED KINGDOM
Covered Properties
(3)
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates
Application:
16/987,348 →
Publication:
US 2021/0137940
Pyrrolobenzodiazepine-Antibody Conjugates
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 31, 2020
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: A.T. DEVELOPMENT SWITZERLAND SÀRL
Reel/Frame 053649/0470 →
Assignment of Assignor's Interest
Sep 3, 2020
From: A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 053687/0645 →
Assignment of Assignor's Interest
Sep 9, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 053726/0617 →
Security Interest
Sep 7, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 061387/0715 →
Patent Security Agreement
Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →
Assignment of Assignor's Interest
Feb 13, 2023
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 062669/0995 →
Patent Security Agreement
Nov 8, 2023
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 065521/0109 →
Patent Security Agreement
Jul 7, 2025
From: ADC THERAPEUTICS SA
To: BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.)
Reel/Frame 071832/0069 →